Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Latest News about Novo Nordisk A/S

Recent news which mentions Novo Nordisk A/S

< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Hims & Hers to offer generic semaglutide in Canada as Novo Nordisk patent lapses
Tags Novo Nordisk A/S Biotech and Pharmaceuticals Eli Lilly and Co
From CNBC.com News
Healthy Returns: Medicaid cuts in Trump’s megabill may affect some drugmakers more than others
Tags Health & Science Healthy Returns Gilead Sciences Inc
From CNBC.com News
Healthy Returns: New weight loss drug data show Eli Lilly is gaining ground
Tags Biotech and Pharmaceuticals Novo Nordisk A/S Health care industry
From CNBC.com News
5 things to know before the stock market opens Tuesday
Tags Markets Economy Technology
From CNBC.com News
Novo Nordisk ends deal with Hims & Hers over sales of Wegovy copycats; HIMS drops 20%
Tags Hims & Hers Health Inc Companies Business News
From CNBC.com News
Healthy Returns: Ozempic, Wegovy linked to rare cases of serious eye condition
Tags Novo Nordisk A/S Healthy Returns Biotech and Pharmaceuticals
From CNBC.com News
Cigna announces new deal for copay caps on Eli Lilly and Novo Nordisk weight loss drugs
Tags CVS Health Corp Social issues Health care industry
From CNBC.com News
Novo Nordisk is betting on a CEO shakeup to regain its weight loss drug edge over Eli Lilly
Tags Business Novo Nordisk A/S Biotech and Pharmaceuticals
From CNBC.com News
Novo Nordisk CEO to step down as competition weighs on Wegovy maker's share price
Tags Europe News Pharmaceuticals Novo Nordisk A/S
From CNBC.com News
Denmark's economy is booming on drug exports — Trump's tariffs threat won't slow it down
Tags Europe Economy AstraZeneca PLC Roche Holding AG
From CNBC.com News
Why Americans pay so much more for prescription drugs
Tags LILLY DRN Pharmaceuticals Breaking News: Politics
From CNBC.com News
Healthy Returns: Novo Nordisk’s Wegovy deal with CVS won't derail Eli Lilly's obesity market dominance
Tags Biotech and Pharmaceuticals Novo Nordisk A/S LILLY DRN
From CNBC.com News
Novo Nordisk cuts 2025 guidance on weaker-than-expected Wegovy sales, posts first-quarter profit beat
Tags LILLY DRN Abbvie Inc Business
From CNBC.com News
How much a $1,000 investment in Hims & Hers at its IPO would be worth now
Tags Hims & Hers Health Inc Novo Nordisk A/S Make It
From CNBC.com News
Hims & Hers brings former Amazon executive into C-suite
Tags Novo Nordisk A/S Technology Internet
From CNBC.com News
Cramer's week ahead: Earnings from Disney, Palantir and Uber
Tags Markets Arm Holdings PLC Uber Technologies Inc
From CNBC.com News
Inside the deal: Roche and Zealand Pharma's $5.3 billion obesity drug gambit
Tags Pfizer Inc Abbvie Inc Roche Holding AG
From CNBC.com News
CVS to boost access to Novo Nordisk's weight loss treatment Wegovy for patients on its drug plans
Tags Business Novo Nordisk A/S Biotech and Pharmaceuticals
From CNBC.com News
Novo Nordisk opens weight loss drug Wegovy to Hims & Hers, Ro and Life MD telehealth
Tags Health & Science Companies Hims & Hers Health Inc
From CNBC.com News
Novo Nordisk scores major legal win that bars many compounded versions of Wegovy, Ozempic
Tags Business Novo Nordisk A/S Biotech and Pharmaceuticals
From CNBC.com News
Healthy Returns: Trump seeks to change Medicare drug price negotiations in a win for pharma
Tags Novo Nordisk A/S Biotech and Pharmaceuticals Humana Inc
From CNBC.com News
5 European stocks to watch this earnings season as Trump's tariffs hit
Tickers OIL
Tags Europe News ASML Holding NV Shell PLC
From CNBC.com News
Eli Lilly's weight loss pill succeeds in first late-stage trial on diabetes patients
Tags Biotech and Pharmaceuticals Novo Nordisk A/S Business
From CNBC.com News
CNBC Daily Open: Consumers are worried over the economy. The White House insists it’ll be fine
Tags JPMorgan Chase & Co Pfizer Inc World Markets
From CNBC.com News
Pfizer scraps daily weight loss pill after liver injury in one patient
Tags US: News Pharmaceuticals LILLY DRN
From CNBC.com News
Autos, pharma, luxury and more: The global sectors soaring after Trump's tariffs walkback
Tags Consumer Goods Breaking News: Economy Europe News
From CNBC.com News
Trump drops Biden's proposal for Medicare to cover obesity drugs like Wegovy and Zepbound
Tags Biotechnology Health care industry Social issues
From CNBC.com News
The biggest winners and losers in Europe as Trump announces sweeping tariffs
Tags Adidas AG Heineken NV Markets
From CNBC.com News
Pharma tariff relief likely short-lived with sector-specific duties on the horizon
Tags Pharmaceuticals Novartis AG Bayer AG
From CNBC.com News
Novo Nordisk's diabetes pill slashes risk of cardiovascular complications by 14% after four years
Tags Breaking News: Business Biotechnology Health care industry
From CNBC.com News
< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.